{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:41:54Z","timestamp":1794408114483,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10741-019-09808-y","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T07:02:39Z","timestamp":1559890959000},"page":"989-995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Trends in the prevalence of malignancy among patients admitted with acute heart failure and associated outcomes: a nationwide population-based study"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-9260","authenticated-orcid":false,"given":"Pradhum","family":"Ram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Bryan","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushal","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahek","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"issue":"1","key":"9808_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330. \nhttps:\/\/doi.org\/10.3322\/caac.21442","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"9808_CR2","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/cncr.31551","volume":"124","author":"KA Cronin","year":"2018","unstructured":"Cronin KA, Lake AJ, Scott S, Sherman RL, Noone AM, Howlader N, Henley SJ, Anderson RN, Firth AU, Ma J, Kohler BA, Jemal A (2018) Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer. 124(13):2785\u20132800. \nhttps:\/\/doi.org\/10.1002\/cncr.31551","journal-title":"Cancer."},{"issue":"6","key":"9808_CR3","first-page":"1","volume":"67","author":"M Heron","year":"2018","unstructured":"Heron M (2018) Deaths: leading causes for 2016. Natl Vital Stat Rep 67(6):1\u201377","journal-title":"Natl Vital Stat Rep"},{"issue":"4","key":"9808_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271\u2013289. \nhttps:\/\/doi.org\/10.3322\/caac.21349","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"9808_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2217\/fca.15.28","volume":"11","author":"S Piper","year":"2015","unstructured":"Piper S, McDonagh T (2015) Heart failure and chemotherapeutic agents. Futur Cardiol 11(4):453\u2013470. \nhttps:\/\/doi.org\/10.2217\/fca.15.28","journal-title":"Futur Cardiol"},{"issue":"2","key":"9808_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD (2018) Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378(2):158\u2013168. \nhttps:\/\/doi.org\/10.1056\/NEJMra1703481","journal-title":"N Engl J Med"},{"issue":"5","key":"9808_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1586\/14779072.2015.1032940","volume":"13","author":"M O\u2019Hare","year":"2015","unstructured":"O\u2019Hare M, Sharma A, Murphy K, Mookadam F, Lee H (2015) Cardio-oncology part I: chemotherapy and cardiovascular toxicity. Expert Rev Cardiovasc Ther 13(5):511\u2013518. \nhttps:\/\/doi.org\/10.1586\/14779072.2015.1032940","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"5","key":"9808_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1586\/14779072.2015.1027686","volume":"13","author":"M O\u2019Hare","year":"2015","unstructured":"O\u2019Hare M, Murphy K, Mookadam F, Sharma A, Lee H (2015) Cardio-oncology part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity. Expert Rev Cardiovasc Ther 13(5):519\u2013527. \nhttps:\/\/doi.org\/10.1586\/14779072.2015.1027686","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"9808_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.critrevonc.2018.03.014","volume":"126","author":"HM Babiker","year":"2018","unstructured":"Babiker HM, McBride A, Newton M, Boehmer LM, Drucker AG, Gowan M, Cassagnol M, Camenisch TD, Anwer F, Hollands JM (2018) Cardiotoxic effects of chemotherapy: a review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system. Crit Rev Oncol Hematol 126:186\u2013200. \nhttps:\/\/doi.org\/10.1016\/j.critrevonc.2018.03.014","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"9808_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","volume":"118","author":"CG Lenneman","year":"2016","unstructured":"Lenneman CG, Sawyer DB (2016) Cardio-oncology: an update on cardiotoxicity of cancer-related treatment. Circ Res 118(6):1008\u20131020. \nhttps:\/\/doi.org\/10.1161\/CIRCRESAHA.115.303633","journal-title":"Circ Res"},{"issue":"4","key":"9808_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","volume":"66","author":"G Curigliano","year":"2016","unstructured":"Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, Cipolla CM (2016) Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. CA Cancer J Clin 66(4):309\u2013325. \nhttps:\/\/doi.org\/10.3322\/caac.21341","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"9808_CR12","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","volume":"291","author":"JF Piccirillo","year":"2004","unstructured":"Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 291(20):2441\u20132447","journal-title":"JAMA."},{"issue":"1","key":"9808_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8\u201327","journal-title":"Med Care"},{"issue":"3","key":"9808_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ejhf.472","volume":"18","author":"A Banke","year":"2016","unstructured":"Banke A, Schou M, Videbaek L, M\u00f8ller JE, Torp-Pedersen C, Gustafsson F, Dahl JS, K\u00f8ber L, Hildebrandt PR, Gislason GH (2016) Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur J Heart Fail 18(3):260\u2013266. \nhttps:\/\/doi.org\/10.1002\/ejhf.472","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"9808_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816.","volume":"138","author":"WC Meijers","year":"2018","unstructured":"Meijers WC, Maglione M, Bakker SJL, Oberhuber R, Kieneker LM, de Jong S, Haubner BJ, Nagengast WB, Lyon AR, van der Vegt B, van Veldhuisen DJ, Westenbrink BD, van der Meer P, Sillj\u00e9 HHW, de Boer RA (2018) Heart failure stimulates tumor growth by circulating factors. Circulation. 138(7):678\u2013691. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030816.","journal-title":"Circulation."},{"issue":"2","key":"9808_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12032-013-0561-4","volume":"30","author":"WY Cheung","year":"2013","unstructured":"Cheung WY, Levin R, Setoguchi S (2013) Appropriateness of cardiovascular care in elderly adult cancer survivors. Med Oncol 30(2):561. \nhttps:\/\/doi.org\/10.1007\/s12032-013-0561-4","journal-title":"Med Oncol"},{"issue":"7","key":"9808_CR17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/bjc.2012.46","volume":"106","author":"TL J\u00f8rgensen","year":"2012","unstructured":"J\u00f8rgensen TL, Hallas J, Friis S, Herrstedt J (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106(7):1353\u20131360. \nhttps:\/\/doi.org\/10.1038\/bjc.2012.46","journal-title":"Br J Cancer"},{"issue":"7","key":"9808_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMsa1407211","volume":"372","author":"BD Carter","year":"2015","unstructured":"Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, Ockene JK, Prentice RL, Speizer FE, Thun MJ, Jacobs EJ (2015) Smoking and mortality\u2014beyond established causes. N Engl J Med 372(7):631\u2013640. \nhttps:\/\/doi.org\/10.1056\/NEJMsa1407211","journal-title":"N Engl J Med"},{"issue":"7","key":"9808_CR19","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1158\/1055-9965.EPI-15-0036","volume":"24","author":"KM Islam","year":"2015","unstructured":"Islam KM, Jiang X, Anggondowati T, Lin G, Ganti AK (2015) Comorbidity and survival in lung cancer patients. Cancer Epidemiol Biomark Prev 24(7):1079\u20131085. \nhttps:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0036","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"9808_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/MLR.0000000000000113","volume":"52","author":"CJ Bradley","year":"2014","unstructured":"Bradley CJ, Dahman B, Anscher M (2014) Prostate cancer treatment and survival: evidence for men with prevalent comorbid conditions. Med Care 52(6):482\u2013489. \nhttps:\/\/doi.org\/10.1097\/MLR.0000000000000113","journal-title":"Med Care"},{"issue":"8","key":"9808_CR21","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jama.2009.1137","volume":"302","author":"A Nanda","year":"2009","unstructured":"Nanda A, Chen MH, Braccioforte MH, Moran BJ, D\u2019Amico AV (2009) Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. JAMA. 302(8):866\u2013873. \nhttps:\/\/doi.org\/10.1001\/jama.2009.1137","journal-title":"JAMA."},{"issue":"2","key":"9808_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.breast.2010.11.002","volume":"20","author":"A Zambelli","year":"2011","unstructured":"Zambelli A, Della Porta MG, Eleuteri E, De Giuli L, Catalano O, Tondini C, Riccardi A (2011) Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. Breast. 20(2):176\u2013183. \nhttps:\/\/doi.org\/10.1016\/j.breast.2010.11.002","journal-title":"Breast."},{"issue":"12","key":"9808_CR23","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.healun.2004.12.108","volume":"24","author":"JA Tallaj","year":"2005","unstructured":"Tallaj JA, Franco V, Rayburn BK, Pinderski L, Benza RL, Pamboukian S, Foley B, Bourge RC (2005) Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure. J Heart Lung Transplant 24(12):2196\u20132201","journal-title":"J Heart Lung Transplant"},{"issue":"18","key":"9808_CR24","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa020265","volume":"347","author":"D Levy","year":"2002","unstructured":"Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347(18):1397\u20131402","journal-title":"N Engl J Med"},{"issue":"3","key":"9808_CR25","doi-asserted-by":"publisher","first-page":"e000053","DOI":"10.1161\/JAHA.113.000053","volume":"2","author":"SW Joffe","year":"2013","unstructured":"Joffe SW, Webster K, McManus DD, Kiernan MS, Lessard D, Yarzebski J, Darling C, Gore JM, Goldberg RJ (2013) Improved survival after heart failure: a community-based perspective. J Am Heart Assoc 2(3):e000053. \nhttps:\/\/doi.org\/10.1161\/JAHA.113.000053","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"9808_CR26","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/cncr.31174","volume":"124","author":"IY Gong","year":"2018","unstructured":"Gong IY, Yan AT, Ko DT, Earle CC, Cheung WY, Peacock S, Hall M, Gale CP, Chan KKW (2018) Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013. Cancer. 124(6):1269\u20131278. \nhttps:\/\/doi.org\/10.1002\/cncr.31174","journal-title":"Cancer."},{"issue":"5","key":"9808_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ejhf.486","volume":"18","author":"M Schmidt","year":"2016","unstructured":"Schmidt M, Ulrichsen SP, Pedersen L, B\u00f8tker HE, S\u00f8rensen HT (2016) Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study. Eur J Heart Fail 18(5):490\u2013499. \nhttps:\/\/doi.org\/10.1002\/ejhf.486","journal-title":"Eur J Heart Fail"},{"key":"9808_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12939-015-0197-4","volume":"14","author":"TH Teng","year":"2015","unstructured":"Teng TH, Katzenellenbogen JM, Hung J, Knuiman M, Sanfilippo FM, Geelhoed E, Bessarab D, Hobbs M, Thompson SC (2015) A cohort study: temporal trends in prevalence of antecedents, comorbidities and mortality in Aboriginal and non-Aboriginal Australians with first heart failure hospitalization, 2000-2009. Int J Equity Health 14:66. \nhttps:\/\/doi.org\/10.1186\/s12939-015-0197-4","journal-title":"Int J Equity Health"},{"issue":"6","key":"9808_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCOUTCOMES.110.957571","volume":"3","author":"S Stewart","year":"2010","unstructured":"Stewart S, Ekman I, Ekman T, Od\u00e9n A, Rosengren A (2010) Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes 3(6):573\u2013580. \nhttps:\/\/doi.org\/10.1161\/CIRCOUTCOMES.110.957571","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"9808_CR30","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ejhf.822","volume":"19","author":"MA Mamas","year":"2017","unstructured":"Mamas MA, Sperrin M, Watson MC, Coutts A, Wilde K, Burton C, Kadam UT, Kwok CS, Clark AB, Murchie P, Buchan I, Hannaford PC, Myint PK (2017) Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland. Eur J Heart Fail 19(9):1095\u20131104. \nhttps:\/\/doi.org\/10.1002\/ejhf.822","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"9808_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mayocp.2015.09.009","volume":"91","author":"SG Al-Kindi","year":"2016","unstructured":"Al-Kindi SG, Oliveira GH (2016) Prevalence of preexisting cardiovascular disease in patients with different types of cancer: The Unmet Need for Onco-Cardiology. Mayo Clin Proc 91(1):81\u201383. \nhttps:\/\/doi.org\/10.1016\/j.mayocp.2015.09.009","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"9808_CR32","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/cncr.20560","volume":"101","author":"CC Earle","year":"2004","unstructured":"Earle CC, Neville BA (2004) Under use of necessary care among cancer survivors. Cancer. 101(8):1712\u20131719","journal-title":"Cancer."}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09808-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09808-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09808-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:15:58Z","timestamp":1591398958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09808-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["9808"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09808-y","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"7 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}